Literature DB >> 16449617

Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa.

Anthon du P Heyns1, Richard J Benjamin, J P Ronel Swanevelder, Megan E Laycock, Brandee L Pappalardo, Robert L Crookes, David J Wright, Michael P Busch.   

Abstract

CONTEXT: The South African National Blood Service collects more than 700,000 units of blood annually from a population in which 11.4% is infected with human immunodeficiency virus 1 (HIV-1). The prevalence of HIV-1 in blood donations increased to 0.26% (1:385) in 1998, indicating that a significant number of window-period infective units were entering the blood supply (risk 3.4/100,000).
OBJECTIVES: To determine whether the implementation of a new donor selection policy and educational program introduced in 1999 was associated with reductions in the incidence and prevalence of HIV-1 in blood donations and the reduced transmission risk.
DESIGN: We compared the prevalence of HIV-1 in 880,534 blood donations collected from 1999 through 2000 with the 791,639 blood donations collected from 2001 through 2002. We estimated the incidence of HIV-1 in 93,378 (1999-2000) and 67,231 (2001-2002) first-time donations and the residual risk for all donations in 2001-2002 using the less-sensitive enzyme-linked immunoassay and incidence-window period model.
SETTING: All blood donors in the Inland region of the South African National Blood Service were analyzed. INTERVENTION: Donor clinics in high HIV prevalence areas were closed. Programs targeting repeat donors and youth were initiated and HIV risk behavior education programs were developed. Structured donor interviews and an enhanced donor self-exclusion questionnaire were institutionalized.
RESULTS: The prevalence of HIV-1 in blood donations declined from 0.17% in 1999-2000 to 0.08% in 2001-2002 after the implementation of the new donor selection and education policy. The number of high-risk donations collected decreased from 2.6% to 1.7% (P<.001), and the likelihood of these donations being infected decreased from 4.8% to 3.25%. The likelihood of first-time donors being recently infected with HIV-1 decreased from 18% to 14% (P = .07) and respective incidence of high-risk donations collected decreased from 2.6% to 1.7%. Donations from the majority black population declined from 6.6% to 4.2% (P<.001). Analysis of HIV-1 incidence in 2001-2002 suggests a residual risk of collecting a window period infectious unit of 2.6/100,000.
CONCLUSION: The implementation of enhanced education and selection policies in South Africa was associated with decreased prevalence of HIV-1 in blood donations.

Entities:  

Mesh:

Year:  2006        PMID: 16449617     DOI: 10.1001/jama.295.5.519

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  11 in total

1.  Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes.

Authors:  Surender Khurana; James Needham; Susan Park; Bonnie Mathieson; Michael P Busch; George Nemo; Phillipe Nyambi; Susan Zolla-Pazner; Suman Laal; Joseph Mulenga; Elwyn Chomba; Eric Hunter; Susan Allen; James McIntyre; Indira Hewlett; Sherwin Lee; Shixing Tang; Elliot Cowan; Chris Beyrer; Marcus Altfeld; Xu G Yu; Anatole Tounkara; Ousmane Koita; Anatoli Kamali; Nga Nguyen; Barney S Graham; Deborah Todd; Peter Mugenyi; Omu Anzala; Eduard Sanders; Nzeera Ketter; Patricia Fast; Hana Golding
Journal:  J Acquir Immune Defic Syndr       Date:  2006-11-01       Impact factor: 3.731

2.  Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors.

Authors:  Claude Tayou Tagny; Maxime Diané Kouao; Hamane Touré; Jalel Gargouri; Ahamada Said Fazul; Siaka Ouattara; Ludovic Anani; Habiba Othmani; Lochina Feteke; Honorine Dahourou; Guy Olivier Mbensa; Simplice Molé; Yacouba Nébié; Madeleine Mbangue; Michel Toukam; Mahommed Ould Boulahi; Lalatiana Valisoa Andriambelo; Olivat Rakoto; Mounirou Baby; Rakia Yahaya; Amelia Bokilo; Florent Senyana; Dora Mbanya; Caroline Shiboski; Edward L Murphy; Jean Jacques Lefrère
Journal:  Transfusion       Date:  2011-10-20       Impact factor: 3.157

3.  Motivators and deterrents to blood donation among Black South Africans: a qualitative analysis of focus group data.

Authors:  T N Muthivhi; M G Olmsted; H Park; M Sha; V Raju; T Mokoena; E M Bloch; E L Murphy; R Reddy
Journal:  Transfus Med       Date:  2015-06-23       Impact factor: 2.019

Review 4.  Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges.

Authors:  Evan M Bloch; Marion Vermeulen; Edward Murphy
Journal:  Transfus Med Rev       Date:  2011-08-26

Review 5.  Translation of biomedical prevention strategies for HIV: prospects and pitfalls.

Authors:  Sten H Vermund; José A Tique; Holly M Cassell; Megan E Pask; Philip J Ciampa; Carolyn M Audet
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

6.  High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection.

Authors:  Zhong-Min Ma; Mars Stone; Mike Piatak; Becky Schweighardt; Nancy L Haigwood; David Montefiori; Jeffrey D Lifson; Michael P Busch; Christopher J Miller
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

7.  Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors.

Authors:  Elin S Gray; Natasha Taylor; Diane Wycuff; Penny L Moore; Georgia D Tomaras; Constantinos Kurt Wibmer; Adrian Puren; Allan DeCamp; Peter B Gilbert; Blake Wood; David C Montefiori; James M Binley; George M Shaw; Barton F Haynes; John R Mascola; Lynn Morris
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

8.  Assessing the residual risk for transfusion-transmitted infections in the Philippine blood supply.

Authors:  Hilton Y Lam; Vicente Y Belizario; Noel R Juban; Marissa M Alejandria; Nina Castillo-Carandang; Elizabeth Arcellana-Nuqui; Ma Angelina Mirasol; Cynthia P Cordero; Olivia T Sison; Adovich S Rivera
Journal:  Yale J Biol Med       Date:  2014-09-03

9.  Prevalence of human immunodeficiency virus, syphilis, hepatitis B and C in blood donations in Namibia.

Authors:  Rooyen T Mavenyengwa; Munyaradzi Mukesi; Israel Chipare; Esra Shoombe
Journal:  BMC Public Health       Date:  2014-05-05       Impact factor: 3.295

10.  Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries.

Authors:  Evan M Bloch; Ruchika Goel; Silvano Wendel; Thierry Burnouf; Arwa Z Al-Riyami; Ai Leen Ang; Vincenzo DeAngelis; Larry J Dumont; Kevin Land; Cheuk-Kwong Lee; Adaeze Oreh; Gopal Patidar; Steven L Spitalnik; Marion Vermeulen; Salwa Hindawi; Karin Van den Berg; Pierre Tiberghien; Hans Vrielink; Pampee Young; Dana Devine; Cynthia So-Osman
Journal:  Vox Sang       Date:  2020-07-20       Impact factor: 2.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.